Furthermore, MSC-based delivery of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a potent antitumor molecule, could restore the sensitivity of TRAIL-resistant tumor cells to TRAIL-induced apoptosis (Rossignoli et al., 2019). The gene discussed is TNFSF10; the disease is neoplasm.